Incresed glucose metabolism by FDG-PET correlates with reduced tumor angiogenesis in oral squamous cell carcinoma
Incresed glucose metabolism by FDG-PET correlates with reduced tumor angiogenesis in oral squamous cell carcinoma
复制标题
FDG-PET 增加的葡萄糖代谢与口腔鳞状细胞癌中肿瘤血管生成的减少相关
DOI:
10.1007/s10266-011-0024-3
复制
发表时间:
2012
期刊:
影响因子:
2.5
通讯作者:
Sano K.
中科院分区:
文献类型:
--
作者:
Nakamura M;Kitagawa Y;Yamazaki Y;Hata H;Kotsuji M;Fujibayashi Y;Okazawa H;Yonekura Y;Sano K.
The spinocerebellar ataxia type 7 (SCA7) gene product, Ataxin-7 (ATXN7), localizes to the nucleus and has been shown to function as a component of the TATA-binding protein-free TAF-containing-SPT3-TAF9-GCN5-acetyltransferase transcription complex, although cytoplasmic localization of ATXN7 in affected neurons of human SCA7 patients has also been detected. Here, we define a physiological function for cytoplasmic ATXN7. Live imaging reveals that the intracellular distribution of ATXN7 dynamically changes and that ATXN7 distribution frequently shifts from the nucleus to the cytoplasm. Immunocytochemistry and immunoprecipitation demonstrate that cytoplasmic ATXN7 associates with microtubules (MTs), and expression of ATXN7 stabilizes MTs against nocodazole treatment, while ATXN7 knockdown enhances MT degradation. Interestingly, normal and mutant ATXN7 similarly associate with and equally stabilize MTs. Taken together, these findings provide a novel physiological function of ATXN7 in the regulation of cytoskeletal dynamics, and suggest that abnormal cytoskeletal regulation may contribute to SCA7 disease pathology.